Sumitomo Pharma Switzerland

OrganisationROR

Trials

  • NCT06439524

    Collaborator, Phase 3, Recruiting, 110 people, 3 Jun 2024

  • NCT00849888

    Phase 1, Terminated, 2 people, 24 Feb 2009

  • NCT00579527

    Phase 1/2, Completed, 14 people, 24 Dec 2007